Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TS03 Inc Trust Units TSTIF

Healthcare Medical Instruments & Supplies


GREY:TSTIF - Post by User

TS03 Inc Trust Units > Stryker buying Novadaq for 100% premium
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(43)
•••
Comment by Metalsguy1on Jun 20, 2017 1:38am
155 Views
Post# 26381006

RE:RE:RE:RE:Stryker buying Novadaq for 100% premium

RE:RE:RE:RE:Stryker buying Novadaq for 100% premiumEunice, I stand corrected. With such a long history of failures, poor planning, and complete and utter lack of forsight, perhaps there won't be any real movement until the 5 year agreement expires and RR has been replaced by someone better at corporate planning.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities